Evanson Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-16,545
| Closed | -$152K | – | 291 |
|
|
2021
Q2 | $152K | Hold |
16,545
| – | – | 0.02% | 264 |
|
|
2021
Q1 | $82K | Hold |
16,545
| – | – | 0.01% | 275 |
|
|
2020
Q4 | $71K | Hold |
16,545
| – | – | 0.01% | 257 |
|
|
2020
Q3 | $71K | Hold |
16,545
| – | – | 0.01% | 239 |
|
|
2020
Q2 | $74K | Hold |
16,545
| – | – | 0.01% | 227 |
|
|
2020
Q1 | $66K | Hold |
16,545
| – | – | 0.02% | 212 |
|
|
2019
Q4 | $140K | Hold |
16,545
| – | – | 0.03% | 230 |
|
|
2019
Q3 | $113K | Hold |
16,545
| – | – | 0.02% | 228 |
|
|
2019
Q2 | $138K | Hold |
16,545
| – | – | 0.03% | 232 |
|
|
2019
Q1 | $152K | Hold |
16,545
| – | – | 0.03% | 230 |
|
|
2018
Q4 | $181K | Hold |
16,545
| – | – | 0.04% | 215 |
|
|
2018
Q3 | $231K | Hold |
16,545
| – | – | 0.05% | 215 |
|
|
2018
Q2 | $176K | Hold |
16,545
| – | – | 0.03% | 239 |
|
|
2018
Q1 | $143K | Hold |
16,545
| – | – | 0.03% | 242 |
|
|
2017
Q4 | $156K | Hold |
16,545
| – | – | 0.03% | 235 |
|
|
2017
Q3 | $130K | Hold |
16,545
| – | – | 0.03% | 225 |
|
|
2017
Q2 | $142K | Hold |
16,545
| – | – | 0.03% | 214 |
|
|
2017
Q1 | $117K | Hold |
16,545
| – | – | 0.03% | 217 |
|
|
2016
Q4 | $70K | Hold |
16,545
| – | – | 0.02% | 213 |
|
|
2016
Q3 | $83K | Hold |
16,545
| – | – | 0.02% | 198 |
|
|
2016
Q2 | $59K | Hold |
16,545
| – | – | 0.02% | 200 |
|
|
2016
Q1 | $57K | Hold |
16,545
| – | – | 0.02% | 194 |
|
|
2015
Q4 | $56K | Hold |
16,545
| – | – | 0.02% | 194 |
|
|
2015
Q3 | $86K | Hold |
16,545
| – | – | 0.03% | 193 |
|
|
2015
Q2 | $113K | Hold |
16,545
| – | – | 0.04% | 203 |
|
|
2015
Q1 | $118K | Hold |
16,545
| – | – | 0.04% | 189 |
|
|
2014
Q4 | $123K | Hold |
16,545
| – | – | 0.05% | 181 |
|
|
2014
Q3 | $153K | Buy |
+16,545
| New | +$224K | 0.06% | 176 |
|
Other funds holding KIN
Evanson Asset Management's KIN Position: Q3 2021 in Review
Evanson Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 16,545 shares — an estimated $152K sold.
Evanson Asset Management first reported a position in KIN in Q3 2014 and held it in 28 quarters. The position peaked at $231K in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Evanson Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Evanson Asset Management sold 16,545 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $152K.
- Evanson Asset Management first reported a position in Kindred Biosciences, Inc. in Q3 2014 and held it in 28 quarters.
- Evanson Asset Management's Kindred Biosciences, Inc. position peaked at $231K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Evanson Asset Management's 13F filing for Q3 2021, filed 13 Oct 2021.